SFG
NVAX icon

SevenBridge Financial Group’s Novavax NVAX Stock Holding History

SevenBridge Financial Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-110
Closed -$4K – 656
2016
Q4 		$4K Hold
110
– – ﹤0.01% 545
2016
Q3 		$4K Buy
110
+100
+1,000% +$12.9K ﹤0.01% 532
2016
Q2 		$1K Buy
+10
New +$1.15K ﹤0.01% 721

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SevenBridge Financial Group's NVAX Position: Q1 2017 in Review

SevenBridge Financial Group sold out of Novavax (NVAX) in Q1 2017, closing a stake of 110 shares — an estimated $4K sold.

SevenBridge Financial Group first reported a position in NVAX in Q2 2016 and held it in 3 quarters. The position peaked at $4K in Q4 2016. 129 funds tracked by Wall St. Rank hold NVAX as of Q1 2017.

  • SevenBridge Financial Group reported no remaining Novavax position as of Q1 2017 after selling out during the quarter.
  • SevenBridge Financial Group sold 110 Novavax shares in Q1 2017, an estimated $4K.
  • SevenBridge Financial Group first reported a position in Novavax in Q2 2016 and held it in 3 quarters.
  • SevenBridge Financial Group's Novavax position peaked at $4K in Q4 2016.
  • 129 funds tracked by Wall St. Rank held Novavax as of Q1 2017.

Based on SevenBridge Financial Group's 13F filing for Q1 2017, filed 15 May 2017.